A. Chemaissani

844 total citations
13 papers, 650 citations indexed

About

A. Chemaissani is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, A. Chemaissani has authored 13 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 3 papers in Surgery. Recurrent topics in A. Chemaissani's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Cancer Treatment and Pharmacology (4 papers). A. Chemaissani is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Cancer Treatment and Pharmacology (4 papers). A. Chemaissani collaborates with scholars based in Germany, Italy and Spain. A. Chemaissani's co-authors include Rafael Rosell, Robert Pirker, Andrea Ardizzoni, U. Gatzemeier, U. Keppler, Pascaline Berthet, Jan Bogaerts, J.L. Breau, Daniel Betticher and M. Nicholson and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

A. Chemaissani

12 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Chemaissani Germany 9 508 464 124 72 39 13 650
D. Brisgand France 5 666 1.3× 639 1.4× 155 1.3× 50 0.7× 43 1.1× 8 840
L Portalone Italy 11 427 0.8× 418 0.9× 156 1.3× 73 1.0× 22 0.6× 26 668
Wayne Saville United States 4 323 0.6× 347 0.7× 57 0.5× 34 0.5× 23 0.6× 8 446
C. Harris Spiridonidis United States 10 706 1.4× 725 1.6× 148 1.2× 127 1.8× 48 1.2× 23 1.0k
U. Keppler Germany 6 463 0.9× 338 0.7× 112 0.9× 27 0.4× 20 0.5× 8 579
Athina Agelidou Greece 14 580 1.1× 629 1.4× 146 1.2× 37 0.5× 18 0.5× 31 756
Jane Bromund United States 9 467 0.9× 447 1.0× 127 1.0× 42 0.6× 11 0.3× 17 609
Eugene Paschold United States 8 347 0.7× 428 0.9× 154 1.2× 33 0.5× 16 0.4× 12 592
H. Doubre France 12 524 1.0× 372 0.8× 113 0.9× 58 0.8× 27 0.7× 33 629

Countries citing papers authored by A. Chemaissani

Since Specialization
Citations

This map shows the geographic impact of A. Chemaissani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Chemaissani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Chemaissani more than expected).

Fields of papers citing papers by A. Chemaissani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Chemaissani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Chemaissani. The network helps show where A. Chemaissani may publish in the future.

Co-authorship network of co-authors of A. Chemaissani

This figure shows the co-authorship network connecting the top 25 collaborators of A. Chemaissani. A scholar is included among the top collaborators of A. Chemaissani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Chemaissani. A. Chemaissani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Schmid‐Bindert, Gerald, A. Chemaissani, J.R. Fischer, et al.. (2009). Pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in early-stage NSCLC. Journal of Clinical Oncology. 27(15_suppl). 7565–7565. 10 indexed citations
2.
Kamp, Marcel A., et al.. (2009). Invasive pulmonale Aspergillose. Der Anaesthesist. 58(3). 262–267. 1 indexed citations
3.
Müller, Roberto L., P Weller, & A. Chemaissani. (2008). Pleurafibrose als Nebenwirkung einer langjährigen Methysergid-Therapie. DMW - Deutsche Medizinische Wochenschrift. 116(38). 1433–1436. 1 indexed citations
4.
5.
Schuette, Wolfgang, Thomas Blankenburg, Michael Schneider, et al.. (2006). Multicenter Randomized Trial for Stage IIIB/IV Non–Small-Cell Lung Cancer Using Every-3-Week Versus Weekly Paclitaxel/Carboplatin. Clinical Lung Cancer. 7(5). 338–343. 39 indexed citations
6.
Rosell, Rafael, U. Gatzemeier, Daniel Betticher, et al.. (2002). Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Annals of Oncology. 13(10). 1539–1549. 219 indexed citations
7.
Laack, Eckart, Thorsten Mende, A. Chemaissani, et al.. (2001). Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer. European Journal of Cancer. 37(5). 583–590. 27 indexed citations
8.
Laack, Eckart, Thorsten Mende, A. Chemaissani, et al.. (1999). A multicenter phase II trial with gemcitabine (GEM) and vinorelbine (VNR) in the treatment of non-small cell lung cancer (NSCLC) stage IIIB and IV. European Journal of Cancer. 35. S252–S252. 1 indexed citations
9.
Manegold, C., Bengt Bergman, A. Chemaissani, et al.. (1997). Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer. Annals of Oncology. 8(6). 525–529. 91 indexed citations
10.
Chemaissani, A., et al.. (1997). [Pleurodesis in malignant pleural effusion: bleomycin vs. mitoxantrone].. PubMed. 51(4). 367–72. 8 indexed citations
11.
Manegold, C., P. Drings, Joachim von Pawel, et al.. (1997). A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.. PubMed. 24(3 Suppl 8). S8–13. 9 indexed citations
12.
Fauser, A. A., Bernard Duclos, A. Chemaissani, et al.. (1996). Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Journal of Cancer. 32(9). 1523–1529. 28 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Brisgand Breakdown of academic impact, for papers by L Portalone Breakdown of academic impact, for papers by Wayne Saville Breakdown of academic impact, for papers by C. Harris Spiridonidis Breakdown of academic impact, for papers by U. Keppler Breakdown of academic impact, for papers by Athina Agelidou Breakdown of academic impact, for papers by Jane Bromund Breakdown of academic impact, for papers by Eugene Paschold Breakdown of academic impact, for papers by H. Doubre
Rankless by CCL
2026